Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

New Data Confirm That Diovan(R) And Valsartan-Based Combinations Offer Patients Sustained, 24-hr BP-lowering Efficacy
Data presented at the 19th Scientific Meeting of the European Society of Hypertension (ESH) confirm that Diovan® (valsartan) and valsartan-based combinations deliver sustained, 24-hr blood pressure (BP)-lowering efficacy2-6.
generic viagra online
First Potential Lupus-Specific Treatment In Sight
Today, Human Genome Sciences (HGS) and GlaxoSmithKline (GSK) announced positive results from a year-long clinical trial of BENLYSTA for treating lupus. When the 52-week study concluded, the lupus patients who were treated with BENLYSTA had improvement in overall disease activity without clinically significant flare-ups in one or more isolated organs when compared to patients who received the placebo (inactive agent). The patients receiving BENLYSTA also were able to reduce their intake of steroid medications. The study is the largest ever to be completed for lupus and the first Phase III (late stage) trial of a new biologic immune therapy for lupus to succeed in meeting its primary endpoint and most of its secondary endpoints.
News of the day
Unique OCD Conference Specifically For Family Members
Experts from the Institute of Psychiatry will tell attendees of a unique conference on the 25th July in Reading that health professionals often fail to correctly identify when someone suffers from Obsessive-Compulsive Disorder (OCD). As a consequence, the burden of this very disabling and distressing condition tends to fall on family members.
Diagnostics

The Journal "Foot & Ankle Specialist" Accepted In Medline

Foot & Ankle Specialist (FAS), published by SAGE, has been accepted for inclusion in MEDLINE, the premier bibliographic database of the U.S. National Library of Medicine (NLM), containing more than 16 million journal article citations. "FAS is privileged to be among the high-quality journals accepted into MEDLINE," said co-editor Gregory C. Berlet, MD. "Researchers and clinicians concerned with foot and ankle care will now be better able to access and disseminate the techniques and advancements published in the journal." Foot & Ankle Specialist is a peer-reviewed bimonthly journal offering clinical information for foot and ankle caregivers. Written and edited by orthopaedic surgeons and podiatrists, FAS offers the latest techniques and advancements in foot and ankle treatment through research reports and reviews, technical perspectives, case studies, and other evidence-based articles. FAS enables practitioners to address a broad range of disorders and provide their patients with the best current diagnosis and therapy. "SAGE is very pleased to see the important work published in FAS now included in this prestigious database," said Ron Epstein, SAGE Director, STM Journals. "It is a testament to the quality of the work and dedication of the editors Gregory C. Berlet and Babak Baravarian and the entire editorial team." Jim Gilden SAGE Publications


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009